Based on SEC filing data. A biotech corporation in Palo Alto, CA raised $6.0M through a convertible note financing round. The company is at the growth stage of development.
Get notified the moment EIGER BIOPHARMACEUTICALS INC files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.